DiaMedica Therapeutics
DMAC
DMAC
77 hedge funds and large institutions have $82.5M invested in DiaMedica Therapeutics in 2025 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
23% more call options, than puts
Call options by funds: $178K | Put options by funds: $145K
4.15% more ownership
Funds ownership: 20.44% → 24.59% (+4.1%)
Holders
77
Holding in Top 10
1
Calls
$178K
Puts
$145K
Top Buyers
| 1 | +$8.79M | |
| 2 | +$6.44M | |
| 3 | +$2.64M | |
| 4 |
Morgan Stanley
New York
|
+$1.84M |
| 5 |
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture
Dallas,
Texas
|
+$1.22M |
Top Sellers
| 1 | -$4.72M | |
| 2 | -$550K | |
| 3 | -$207K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$191K |
| 5 |
Barclays
London,
United Kingdom
|
-$190K |
